ARHGDIA anticorps
Aperçu rapide pour ARHGDIA anticorps (ABIN6989737)
Antigène
Voir toutes ARHGDIA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-204 of human ARHGDIA (NP_001172006.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IF(ICC) 1:50-200
IF() -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- ARHGDIA (rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA))
-
Autre désignation
- ARHGDIA
-
Sujet
-
Synonyms: ARHGDIA,GDIA1,HEL-S-47e,NPHS8,RHOGDI,RHOGDI-1
Background: This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants.
-
ID gène
- 396
-
UniProt
- P52565
-
Pathways
- Neurotrophin Signaling Pathway
Antigène
-